Trinity Biotech PLC (TRIB)
1.83
+0.02
(+1.10%)
USD |
NASDAQ |
Apr 23, 16:00
1.84
+0.01
(+0.55%)
Pre-Market: 20:00
Trinity Biotech Net Income (TTM): -28.60M for Sept. 30, 2023
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| September 30, 2023 | -28.60M |
| June 30, 2023 | -30.82M |
| March 31, 2023 | -34.54M |
| December 31, 2022 | -41.01M |
| September 30, 2022 | -32.20M |
| June 30, 2022 | -21.93M |
| March 31, 2022 | -13.01M |
| December 31, 2021 | 0.875M |
| September 30, 2021 | -7.884M |
| June 30, 2021 | -1.88M |
| March 31, 2021 | -2.564M |
| December 31, 2020 | -6.388M |
| September 30, 2020 | -19.69M |
| June 30, 2020 | -26.99M |
| March 31, 2020 | -30.92M |
| December 31, 2019 | -28.91M |
| September 30, 2019 | -29.55M |
| June 30, 2019 | -28.68M |
| March 31, 2019 | -22.68M |
| December 31, 2018 | -22.09M |
| September 30, 2018 | -41.00M |
| June 30, 2018 | -41.45M |
| March 31, 2018 | -41.14M |
| December 31, 2017 | -40.27M |
| September 30, 2017 | -98.27M |
| Date | Value |
|---|---|
| June 30, 2017 | -99.24M |
| March 31, 2017 | -98.03M |
| December 31, 2016 | -100.63M |
| September 30, 2016 | 3.066M |
| June 30, 2016 | 15.85M |
| March 31, 2016 | 16.44M |
| December 31, 2015 | 21.79M |
| September 30, 2015 | 23.09M |
| June 30, 2015 | 15.19M |
| March 31, 2015 | 16.81M |
| December 31, 2014 | 17.21M |
| September 30, 2014 | 17.73M |
| June 30, 2014 | 10.38M |
| March 31, 2014 | 9.891M |
| December 31, 2013 | 9.646M |
| September 30, 2013 | 9.476M |
| June 30, 2013 | 16.92M |
| March 31, 2013 | 17.40M |
| December 31, 2012 | 17.34M |
| September 30, 2012 | 16.92M |
| June 30, 2012 | 16.39M |
| March 31, 2012 | 15.95M |
| December 31, 2011 | 15.59M |
| September 30, 2011 | 15.21M |
| June 30, 2011 | 14.19M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-41.01M
Minimum
Dec 2022
0.875M
Maximum
Dec 2021
-21.37M
Average
-27.79M
Median
Net Income (TTM) Benchmarks
| Amarin Corp PLC | -59.11M |
| Avadel Pharmaceuticals PLC | -160.28M |
| DBV Technologies SA | -72.73M |
| Adaptimmune Therapeutics PLC | -113.87M |
| Akari Therapeutics PLC | -10.01M |